107 related articles for article (PubMed ID: 3058966)
1. A synthetic luteinizing hormone releasing hormone vaccine II. Temporal aspects of titer development and formulation trials in BALB/c mice.
Silversides DW; Allen AF; Misra V; Murphy BD; Mapletoft RJ
J Reprod Immunol; 1988 Oct; 14(1):47-58. PubMed ID: 3058966
[TBL] [Abstract][Full Text] [Related]
2. A synthetic luteinizing hormone releasing hormone vaccine. I. Conjugation and specificity trials in BALB/c mice.
Silversides DW; Allen AF; Misra V; Qualtiere L; Mapletoft RJ; Murphy BD
J Reprod Immunol; 1988 Aug; 13(3):249-61. PubMed ID: 3050069
[TBL] [Abstract][Full Text] [Related]
3. Comparison of conventional adjuvants and 'adjuvant-free' monoclonal antibody targeting for stimulating antibody responses against a conjugate of luteinizing hormone releasing hormone and avidin.
Tiong GK; Gill HS; Lofthouse S; Puri NK
Vaccine; 1993; 11(4):425-30. PubMed ID: 8470426
[TBL] [Abstract][Full Text] [Related]
4. Development of recombinant ovalbumin-luteinizing hormone releasing hormone as a potential sterilization vaccine.
Zhang Y; Rozell TG; deAvila DM; Bertrand KP; Reeves JJ
Vaccine; 1999 Apr; 17(17):2185-91. PubMed ID: 10367953
[TBL] [Abstract][Full Text] [Related]
5. Immunization of beef heifers against gonadotropin-releasing hormone prevents luteal activity and pregnancy: Effect of conjugation to different proteins and effectiveness of adjuvants.
Vizcarra JA; Karges SL; Wettemann RP
J Anim Sci; 2012 May; 90(5):1479-88. PubMed ID: 22147471
[TBL] [Abstract][Full Text] [Related]
6. Immunization of sheep against modified peptides of gonadotropin releasing hormone conjugated to carriers.
Goubau S; Silversides DW; González A; Laarveld B; Mapletoft RJ; Murphy BD
Domest Anim Endocrinol; 1989 Oct; 6(4):339-47. PubMed ID: 2695285
[TBL] [Abstract][Full Text] [Related]
7. Parenteral administration of GnRH constructs and adjuvants: immune responses and effects on reproductive tissues of male mice.
Sharma S; McDonald I; Miller L; Hinds LA
Vaccine; 2014 Sep; 32(43):5555-63. PubMed ID: 25130539
[TBL] [Abstract][Full Text] [Related]
8. Antigenic and immunogenic properties of totally synthetic peptide-based anti-fertility vaccines.
Ghosh S; Jackson DC
Int Immunol; 1999 Jul; 11(7):1103-10. PubMed ID: 10383943
[TBL] [Abstract][Full Text] [Related]
9. Effect of active and passive immunization with luteinizing hormone-releasing hormone on serum luteinizing hormone and follicle-stimulating hormone levels and the ultrastructure of the pituitary gonadotrophs in castrated male rats.
Arimura A; Shino M; de la Cruz KG; Rennels EG; Schally AV
Endocrinology; 1976 Jul; 99(1):291-303. PubMed ID: 780100
[TBL] [Abstract][Full Text] [Related]
10. Active immunization of heifers against luteinizing hormone-releasing hormone, human chorionic gonadotropin and bovine luteinizing hormone.
Johnson HE; DeAvila DM; Chang CF; Reeves JJ
J Anim Sci; 1988 Mar; 66(3):719-26. PubMed ID: 3288600
[TBL] [Abstract][Full Text] [Related]
11. Highly immunogenic and totally synthetic lipopeptides as self-adjuvanting immunocontraceptive vaccines.
Zeng W; Ghosh S; Lau YF; Brown LE; Jackson DC
J Immunol; 2002 Nov; 169(9):4905-12. PubMed ID: 12391202
[TBL] [Abstract][Full Text] [Related]
12. Synthetic luteinizing hormone releasing hormone (LHRH) vaccine for effective androgen deprivation and its application to prostate cancer immunotherapy.
Finstad CL; Wang CY; Kowalski J; Zhang M; Li ML; Li XM; Xia WG; Bosland MC; Murthy KK; Walfield AM; Koff WC; Zamb TJ
Vaccine; 2004 Mar; 22(9-10):1300-13. PubMed ID: 15003660
[TBL] [Abstract][Full Text] [Related]
13. Assessment of gold nanoparticles as a size-dependent vaccine carrier for enhancing the antibody response against synthetic foot-and-mouth disease virus peptide.
Chen YS; Hung YC; Lin WH; Huang GS
Nanotechnology; 2010 May; 21(19):195101. PubMed ID: 20400818
[TBL] [Abstract][Full Text] [Related]
14. Vaccines for control of fertility and hormone dependent cancers.
Talwar GP; Singh O; Pal R; Chatterjee N
Int J Immunopharmacol; 1992 Apr; 14(3):511-4. PubMed ID: 1618603
[TBL] [Abstract][Full Text] [Related]
15. Immunization against luteinizing hormone-releasing hormone fusion proteins does not decrease prostate cancer in the transgenic adenocarcinoma mouse prostate model.
Hill RE; de Avila DM; Bertrand KP; Greenberg NM; Reeves JJ
Exp Biol Med (Maywood); 2003 Jul; 228(7):818-22. PubMed ID: 12876301
[TBL] [Abstract][Full Text] [Related]
16. Luteinizing hormone-releasing hormone fusion protein vaccines block estrous cycle activity in beef heifers.
Stevens JD; Sosa JM; deAvila DM; Oatley JM; Bertrand KP; Gaskins CT; Reeves JJ
J Anim Sci; 2005 Jan; 83(1):152-9. PubMed ID: 15583055
[TBL] [Abstract][Full Text] [Related]
17. Characterization of high affinity monoclonal antibodies against the luteinizing hormone-releasing hormone.
Saavedra R; Bravo PJ; Charli JL; Herion P
Hybridoma; 1987 Dec; 6(6):663-72. PubMed ID: 2449391
[TBL] [Abstract][Full Text] [Related]
18. Immunization of melanoma patients with BEC2-keyhole limpet hemocyanin plus BCG intradermally followed by intravenous booster immunizations with BEC2 to induce anti-GD3 ganglioside antibodies.
Yao TJ; Meyers M; Livingston PO; Houghton AN; Chapman PB
Clin Cancer Res; 1999 Jan; 5(1):77-81. PubMed ID: 9918205
[TBL] [Abstract][Full Text] [Related]
19. GD3 vaccines for melanoma: superior immunogenicity of keyhole limpet hemocyanin conjugate vaccines.
Helling F; Shang A; Calves M; Zhang S; Ren S; Yu RK; Oettgen HF; Livingston PO
Cancer Res; 1994 Jan; 54(1):197-203. PubMed ID: 8261439
[TBL] [Abstract][Full Text] [Related]
20. Induction of early and bioeffective antibody response in rodents with the luteinizing hormone-releasing hormone vaccine given as a single dose in biodegradable microspheres along with alum.
Diwan M; Dawar H; Talwar GP
Prostate; 1998 Jun; 35(4):279-84. PubMed ID: 9609551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
